The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
Abstract
Allogeneic transplantation of islets of Langerhans was facilitated by the cotransplantation of syngeneic myoblasts genetically engineered to express the Fas ligand (FasL). Composite grafting of allogeneic islets with syngeneic myoblasts expressing FasL protected the islet graft from immune rejection and maintained normoglycemia for more than 80 days in mice with streptozotocin-induced diabetes. Graft survival was not prolonged with composite grafts of unmodified myoblasts or Fas-expressing myoblasts. Islet allografts transplanted separately from FasL-expressing myoblasts into the contralateral kidney were rejected, as were similarly transplanted third-party thyroid allografts. Thus, the FasL signal provided site- and immune-specific protection of islet allografts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K., Krammer, P. H., & Möller, P. (1993) · PubMed · Cited by 625
Fas and FasL in the homeostatic regulation of immune responses
Lynch, D. H., Ramsdell, F., & Alderson, M. R. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80079-4 · Cited by 558
Purification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
Fas and Fas Ligand: A Death Factor and Its Receptor
Nagata, S. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60672-0 · Cited by 338
Systemic Delivery of Human Growth Hormone by Injection of Genetically Engineered Myoblasts
Dhawan, J., Pan, L. C., Pavlath, G. K., Travis, M. A., Lanctot, A. M., & Blau, H. M. (1991) · Science · doi:10.1126/science.1962213 · Cited by 317
Ramsdell, F., Seaman, M. S., Miller, R. E., Picha, K. S., Kennedy, M. K., & Lynch, D. H. (1994) · International Immunology · doi:10.1093/intimm/6.10.1545 · Cited by 311
Systemic Delivery of Recombinant Proteins by Genetically Modified Myoblasts
Barr, E., & Leiden, J. M. (1991) · Science · doi:10.1126/science.1962212 · Cited by 281
Local Fas/APO‐1 (CD95) ligand‐mediated tumor cell killing in vivo
Rensing‐Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S. M., Weller, M., Aebischer, P., Krammer, P. H., & Fontana, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250821 · Cited by 191
Self-citationTCR/CD3 coupling to Fas-based cytotoxicity.
Vignaux, F., Vivier, E., Malissen, B., Depraetere, V, Nagata, S., & Golstein, P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.781 · Cited by 187
Fas‐mediated Cytotoxicity ‐ A New Immunoregulatory and Pathogenic Function of Thl CD4+ T Cells
YAGITA, H., Hanabuchi, S., ASANO, Y., TAMURA, T., NARIUCHI, H., & Okumura, K. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00691.x · Cited by 64
Cantini, M., Massimino, M. L., Catani, C., et al. (1994) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631405 · Cited by 36
Cited by
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Self-citationMaldonado-López, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., & Moser, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.587 · Cited by 984
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
Nagata, S. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.29 · Cited by 779
Metadata
- Authors
- Lau, H. T., Yu, M., Fontana, A., & Stoeckert, C. J.
- Venue
- Science
- Published
- 1996-07-05
- Volume
- 273
- Issue
- 5271
- Pages
- 109-112
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2078901980
- Cited by
- 445
- References
- 17
- FWCI
- 84.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.